Fig. 3From: A compilation of antimicrobial susceptibility data from a network of 13 Lebanese hospitals reflecting the national situation during 2015–2016Percentage of resistance among six clinically important bacteria in Lebanon during 2011–2013 and 2015–2016, described by the World Health Organization as priority organisms for research and development of new antimicrobials. KEY: CAR carbapenem, FQ fluoroquinolone, MET methicillin, 3GC third-generation cephalosporins, R resistant. N.B. P < 0.05 is considered statistically significantBack to article page